Primary outcome measure
death
PROGRESSION, BONE METASTASES
Progression-free survival from randomization to progression of bone metastases on WB-DWI (Blinded independent central review (BICR)) or to death from any cause is the primary endpoint. The efficacy of treatment will be assessed based on WB-DWI results as interpreted by central judgement. Progression of bone metastases will be assessed by evaluators both inside and outside the field of radiotherapy. Evaluation will be based on the MET-RADS-P [